Trial record 1 of 1 for:    Open Studies | "Meaningful Use"
Previous Study | Return to List | Next Study

Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Children's Hospital of Philadelphia
Sponsor:
Collaborators:
American Academy of Pediatrics
DARTNet Institute
Information provided by (Responsible Party):
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01966068
First received: October 11, 2013
Last updated: April 25, 2014
Last verified: April 2014
  Purpose

This study uses a newly published, evidence-based conceptual model to study the determinants of implementation success, implementation outcomes, and health care outcomes resulting from implementing an asthma portal, MyAsthma, in the national, Agency for Health Care Research and Quality(AHRQ)-funded, Center for Pediatric Practice Research and Learning. Technically, the portal will be implemented with 2 innovative approaches that facilitate rapid cycle evaluation in multiple Electronic Health Records (EHRs). Although many patient portals are simple vehicles for transferring information about upcoming appointments, test results or laboratory findings, the asthma portal in this project extends this basic functionality to provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' preferences and goals. Because asthma is an AHRQ priority condition which addresses three AHRQ priority criteria (children, low income, and special health care needs), our study will use this population to focus on stage 3 Meaningful Use (MU3) objectives. It is the hope that by conducting this study, translational knowledge will be gained to make recommendations for practice implementation and actionable policy statements.


Condition Intervention
Asthma
Other: MyAsthma Web Portal

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

Resource links provided by NLM:


Further study details as provided by Children's Hospital of Philadelphia:

Primary Outcome Measures:
  • Use of the MyAsthma Portal Survey [ Time Frame: Each subject will contribute data up to 3 times over a 3 month period ] [ Designated as safety issue: No ]
    We will evaluate adoption of the MyAsthma portal by determining which subjects completed the MyAsthma Portal Survey at least once during the study period. We will also measure sustained use of the portal, defined as completion of the MyAsthma Portal Survey more than once during the study period.


Secondary Outcome Measures:
  • Asthma management [ Time Frame: 2 weeks following completion of a MyAsthma portal survey ] [ Designated as safety issue: No ]
    We will measure those making an asthma office visit in the two weeks following completion of a MyAsthma portal survey. We will also measure the number of subjects that refill their asthma medication or make a medication change in the two weeks following completion of a MyAsthma portal survey.


Estimated Enrollment: 1292
Study Start Date: October 2013
Estimated Study Completion Date: September 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MyAsthma Web Portal
The portal, MyAsthma, will provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' concerns and goals. Parents will log into the web portal each month, and the information entered by parents will be shared through the electronic health record with the child's primary care provider.
Other: MyAsthma Web Portal

  Eligibility

Ages Eligible for Study:   6 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Child has a diagnosis of asthma on his/her problem list
  • Aged 6-12

Exclusion Criteria:

  • No visit with in the last 12 months
  • Parent or guardian does not speak or read English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01966068

Contacts
Contact: Alexander Fiks, MD, MSCE 267-426-2304 fiks@email.chop.edu
Contact: Stacia Finch 847-434-7629 sfinch@aap.org

Locations
United States, Illinois
PROS Recruiting
Elk Grove Village, Illinois, United States, 60007
Contact: Stacia Finch    847-434-7629    SFinch@aap.org   
United States, Pennsylvania
PeRC Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Alex G Fiks, MD, MSCE    267-426-2304    fiks@email.chop.edu   
Sponsors and Collaborators
Children's Hospital of Philadelphia
American Academy of Pediatrics
DARTNet Institute
Investigators
Principal Investigator: Alexander Fiks, MD, MSCE Children's Hospital of Philadelphia
  More Information

No publications provided

Responsible Party: Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier: NCT01966068     History of Changes
Other Study ID Numbers: 13-010285
Study First Received: October 11, 2013
Last Updated: April 25, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital of Philadelphia:
Asthma
Pediatrics
Health Technology
Meaningful Use Stage-3
Web Portal

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 22, 2014